🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this phase III study is to determine whether Doxorubicin Tra...
Status
Completed
Location
Gabrail Cancer Center
Start Date
2012-06
Trial ID
NCT01655693
Treatments Being Tested
The purpose of this study is to determine if, once a favorable dose of TI I...
Status
Terminated
Location
Sansum Medical Research Institute
Start Date
2008-09
Trial ID
NCT00747006
Treatments Being Tested
The purpose of this study is to investigate the potential benefits and risk...
Status
Completed
Location
University Health Service, The Hong Kong Polytechnic University
Start Date
2013-07
Trial ID
NCT01891084
Treatments Being Tested
The purpose of this research study is to determine how treatment response m...
Status
Withdrawn
Location
New York State Psychiatric Institute
Start Date
2023-01-31
Trial ID
NCT04836533
This randomized controlled trial evaluates the integration of cone-beam com...
Status
Active Not Recruiting
Location
University Hospital Zurich
Start Date
2024-06-25
Trial ID
NCT06489678
Treatments Being Tested
This study will investigate the Safety and Tolerability of Repeated Subcuta...
Status
Completed
Location
ATP Clinical Research, Inc.
Start Date
2009-12
Trial ID
NCT01023685
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and PK of Vi...
Status
Recruiting
Location
Arkansas Childrens Hospital
Start Date
2022-10-12
Trial ID
NCT05491525
Treatments Being Tested
This is a Phase I, single-center, open-label, randomized,two-way crossover,...
Status
Completed
Location
West China Hospital，Sichuan University
Start Date
2019-01-09
Trial ID
NCT03745625
Colon cancer (CC) is the 5th most common cancer worldwide. Standard care fo...
Status
Recruiting
Location
CHU Dijon Bourgogne
Start Date
2024-06-07
Trial ID
NCT06293625
The first phase of this study will be a parallel, 12-week treatment, Phase ...
Status
Completed
Location
Investigational Site Number : 0320006
Start Date
2021-11-24
Trial ID
NCT05107115
Treatments Being Tested